Vicero Bio
Pre-clinicalRedefining cancer immunotherapy with VINCOBODY technology Next-generation VHH therapeutics conquering critical unmet needs with safer, smarter combination therapies Who We Are Our approach VINCOBODIES: The next generation in immunotherapy We are advancing a new class of multi-specific cancer therapies built on
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Redefining cancer immunotherapy with VINCOBODY technology Next-generation VHH therapeutics conquering critical unmet needs with safer, smarter combination therapies Who We Are Our approach VINCOBODIES: The next generation in immunotherapy We are advancing a new class of multi-specific cancer therapies built on
AntibodiesBiologics